General Discussion / Social Media, page-39

Companies in the child healthcare space in Europe and the U.S must just about be fighting, bidding against each other to partner to distribute or in some way get involved with us. At this moment Novita sits in a very enviable position, being the only approved, scientifically reviewed drug free solution in the space.

Im sure we are not messing around and we don't want to, but we also don't want to rush into something that is not a very good deal in each continent as the ball is firmly in our court so as to speak.

Sounds like ramping but don't be surprised to see us come out of a partner deal in the near future with ownership retained but 10s of millions of dollars heading our way.

This would be chump change for a large healthcare provider to secure a slice of the action in the U.S or Europe for example. It would be win win for anyone paying us as most of any monies at this point would go back into marketing, development and improvement of products.